Pharmacist interventions in osteoporosis management: a systematic review
Authors' conclusion
Pharmacist interventions show promise for improving osteoporosis management.
Study context
- Population
- Adults diagnosed with or at risk of osteoporosis16 articles
- Participants
- 16,307 adults12 studies
- Comparison
- Pharmacist interventions to improve osteoporosis management
- Investigation and treatmentn = 10
- Adherencen = 2
- Outcome
- Investigation, treatment, adherence and patient knowledge
Methodological detailsqualitative analysis, risk of bias assessed (CASP checklists, RoB 2.0), Searched PubMed, Embase, International Pharmaceutical Abstracts and CINAHL from inception to June 2022; studies published 2005–2018
- Qualitative analysis
- Risk of bias assessed (CASP checklists, RoB 2.0)
- Searched PubMed, Embase, International Pharmaceutical Abstracts and CINAHL from inception to June 2022; studies published 2005–2018
Pooled result
As reported in the abstract
- Pharmacist interventions demonstrated benefit for all outcomes; conclusions limited by heterogeneity of interventions and methodological issues
- Patient education and counselling a cornerstone of interventions, with pharmacist–physician collaboration
Original publication
Pharmacist interventions in osteoporosis management: a systematic review. Osteoporos Int. Published 14 October 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →